Phase 2 Prospective Trial of Retreatment with [177Lu]Lu-PSMA-617 Molecular Radiotherapy for Metastatic Castration-Resistant Prostate Cancer-RE-LuPSMA.
Saved in:
| Title: | Phase 2 Prospective Trial of Retreatment with [177Lu]Lu-PSMA-617 Molecular Radiotherapy for Metastatic Castration-Resistant Prostate Cancer-RE-LuPSMA. |
|---|---|
| Authors: | Nikitas J; Department of Radiation Oncology, University of Pennsylvania, Philadelphia, Pennsylvania.; Ahmanson Translational Theranostics Division, UCLA, Los Angeles, California., Holzgreve A; Ahmanson Translational Theranostics Division, UCLA, Los Angeles, California.; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany; and., Juarez J; Ahmanson Translational Theranostics Division, UCLA, Los Angeles, California., Kimura K; Ahmanson Translational Theranostics Division, UCLA, Los Angeles, California., Lira S; Ahmanson Translational Theranostics Division, UCLA, Los Angeles, California., Alam H; Ahmanson Translational Theranostics Division, UCLA, Los Angeles, California., Contreras M; Ahmanson Translational Theranostics Division, UCLA, Los Angeles, California., Theus L; Ahmanson Translational Theranostics Division, UCLA, Los Angeles, California., Nguyen AT; Ahmanson Translational Theranostics Division, UCLA, Los Angeles, California., Ells Z; Ahmanson Translational Theranostics Division, UCLA, Los Angeles, California., Zhu S; Ahmanson Translational Theranostics Division, UCLA, Los Angeles, California., Grogan T; Department of Medicine Statistics Core, UCLA, Los Angeles, California., Elashoff DA; Department of Medicine Statistics Core, UCLA, Los Angeles, California., Unterrainer LM; Ahmanson Translational Theranostics Division, UCLA, Los Angeles, California.; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany; and., Dahlbom M; Ahmanson Translational Theranostics Division, UCLA, Los Angeles, California., Allen-Auerbach M; Ahmanson Translational Theranostics Division, UCLA, Los Angeles, California., Czernin J; Ahmanson Translational Theranostics Division, UCLA, Los Angeles, California., Calais J; Ahmanson Translational Theranostics Division, UCLA, Los Angeles, California; jcalais@mednet.ucla.edu. |
| Source: | Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2026 May 01; Vol. 67 (5), pp. 674-680. Date of Electronic Publication: 2026 May 01. |
| Publication Type: | Journal Article; Clinical Trial, Phase II; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Society of Nuclear Medicine Country of Publication: United States NLM ID: 0217410 Publication Model: Electronic Cited Medium: Internet ISSN: 1535-5667 (Electronic) Linking ISSN: 01615505 NLM ISO Abbreviation: J Nucl Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1535-5667 |
|---|---|
| DOI: | 10.2967/jnumed.125.271231 |
